Work

Selective Inhibition of Histone Deacetylase 6 (HDAC6) and HDAC3 As a Novel Therapeutic Strategy in Mantle Cell Lymphoma (MCL)

Year: 2014

Type: article

Source: Blood

DOI: 10.1182/blood.v124.21.5397.5397

Authors: Fengdong Cheng, Bing Xia, Eva Sahakian, Tint Lwin, Hongwei Wang, Limin Xing, Bijal D. Shah, Patricio PerezVillarroel, Maritza LienlafMoreno, Yizhuo Zhang, Steven N Quayle, Simon S Jones, Javier Pinilla-Ibarz, Alejandro Villagra, Eduardo M. Sotomayor, Jianguo Tao

Institutions: Moffitt Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University General Hospital, Acetylon Pharmaceuticals (United States)

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2338701266

FWCI:

Cites:

Cited by: 2

Related to: 10